DEUTSCHE BANK AG\
BankPosition in SUPN — Supernus Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in SUPN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,964,034
-$3,163,813 QoQ
Shares Held
63,729
-46.2% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Derivatives in SUPN
reported options exposure · as of Dec 31, 2021CallValue
$13,267
CallShares
455
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. SUPN ranks #23 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,851,737 | $420,505,812 | |
| 2 | VTRS |
Viatris Inc
|
7,891,271 | $125,313,379 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
195,269 | $105,802,598 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,037,225 | $102,901,179 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
334,650 | $56,401,907 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
248,743 | $27,595,547 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
323,443 | $26,774,610 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
387,606 | $24,787,402 |
All Filings in SUPN
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,964,034 | 63,729 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $6,127,847 | 118,550 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $5,631,953 | 113,319 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,369,397 | 112,354 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,406,925 | 44,636 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,533,256 | 46,817 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $3,817,880 | 105,583 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,009,295 | 32,370 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $686,377 | 25,659 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,055,806 | 30,953 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $771,106 | 26,645 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $752,770 | 27,304 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $728,111 | 24,222 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,229,391 | 33,933 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $879,265 | 24,650 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $749,675 | 22,147 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,900,447 | 65,714 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $7,423,385 | 229,684 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,271,961 | 283,675 | Shares | Defined | 2022-02-16 | |
| 2021-12-31 | $13,267 | 455 | Call | Defined | 2022-02-16 | |
| 2021-09-30 | $6,160 | 231 | Call | Defined | 2021-11-04 | |
| 2021-09-30 | $6,826,184 | 255,950 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $7,297 | 237 | Call | Defined | 2021-08-11 | |
| 2021-06-30 | $11,380,844 | 369,628 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $6,644,168 | 253,788 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $6,266,474 | 249,065 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,168 | 200 | Call | Defined | 2020-11-12 | |
| 2020-09-30 | $4,303,770 | 206,515 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,528,992 | 274,905 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,293,003 | 127,460 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||